Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

The Lupus Research Alliance (LRA) is proud to announce the recipients of this year's Lupus Innovation Award (LIA), addressing ...

GemPharmatech, a global leader in genetically engineered mouse models and preclinical contract research services, today ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Nurix Therapeutics (NRIX) announced that the U.S. Food and Drug Administration, FDA, has cleared the IND for the IRAK4 degrader ...

Rein Therapeutics (RNTX) announced a publication highlighting the therapeutic potential of Caveolin-1-related peptide LTI-2355 in Idiopathic ...

Background: Obesity is a complex, chronic, stigmatized disease whereby abnormal or excess body fat may impair health or ...

Real-time index price for TSX 60 VIX Index (VIXI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

Nikkei 225 is an index which belongs to the Tokyo Stock Exchange (TSE). The Nihon Keizai Shimbun (Nikkei) calculates the index daily since 1950. The calculation of Nikkei 225 index began on ...

Here below you have a complete description of its most interesting features and benefits so you can make the most of it. The majority of other information websites display prices of a single ...